Fulgent Genetics is transforming into a healthcare company with a focus on oncology, presenting a promising opportunity. Read ...

Researchers have not only found a dream switch but may have figured out how to flip it, potentially transforming sleep medicine as we know it.

Bluebird Bio (BLUE – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Yanan Zhu ...

More young people are ditching college for the workforce than ever before. If energized, they could play a major role in the ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bluebird Bio (BLUE – Research Report), ...

The athleticwear company's latest use of AI allows it to use Google's Imagen tool to create photorealistic backgrounds for ...

Gene therapy company Bluebird Bio on Tuesday announced a 25% reduction of its workforce as part of a restructuring.

Bluebird bio announces restructuring plans to reduce costs by 20% and achieve cash flow break-even by late 2025. The ...

After bluebird bio acknowledged troubles keeping its business operational, the gene therapy biotech is launching a ...

Humacyte’s acellular tissue engineered vessel (ATEV) shows promise in trauma and dialysis. See why I rate HUMA stock as a ...

The city of Twin Falls is working to repair road damage on Blue Lakes Boulevard. Delays, coordination issues with the Idaho ...

(Perhaps the idea of printing “dissolved insects” there seemed unappealing to the food and drug industry.) There are exciting developments ... Hemro/Shutterstock, courtesy of Sasquatch Books Egyptian ...